FDA Update on the Safety of Ixchiq (Chikungunya Vaccine, Live): FDA Safety Communication
FDA Removes Recommended Pause in Use and Approves Required Updated Labeling AUDIENCE: Patient, Health Care Professional, Pharmacy, Cardiology, Neurology, Internal Medicine, Family Practice, Travel Clinics ISSUE: On May 9, 2025, FDA issued a safety …